AdvanCell
Australia - Pullenvale
PharmaceuticalFocus: Radiopharmaceuticals for Cancer
AdvanCell is a life sciences company focused on Radiopharmaceuticals for Cancer.
OncologyNeurology
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0
Pipeline & Clinical Trials
[²¹²Pb]Pb-ADVC001
Prostate CancerClinical Trials (1)
NCT05720130Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).
Phase 1/2ACADESINE 140mg/kg/d
SMDClinical Trials (1)
NCT01813838GFM-Acadesine: A Phase I-II Trial of Acadesine
Phase 1/2Acadesine
Leukemia, B-Cell, ChronicClinical Trials (1)
NCT00559624Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients
Phase 1/2Phase 2
Clinical Trials (1)
NCT01428726A Phase IIa Study of NT-KO-003 for Multiple Sclerosis
Phase 2Phase 2
Clinical Trials (1)
NCT01316406Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2003
Portfolio: 5 clinical trials